銆€銆€ 椋熷搧浼欎即缃戣2025骞?鏈?9鏃ワ紝娆х洘椋熷搧瀹夊叏灞€灏变竴绉嶉鍝侀叾鍐呭垏-1,4-β- 鏈ㄨ仛绯栭叾锛坋ndo-1,4-β-xylanase锛夌殑瀹夊叏鎬ц瘎浠峰彂甯冩剰瑙併€

銆€銆€鎹簡瑙ｏ紝杩欑椋熷搧閰舵槸鐢包a href='//www.sqrdapp.com/news/tag_2434.html' class='zdbq' title='杞熀鍥犵浉鍏抽鍝佽祫璁? target='_blank'>杞熀鍥燑/a> 鏋崏鑺藉鏉嗚弻鑿屾牚DP-Ezd119鐢熶骇鐨勶紝鏃ㄥ湪鐢ㄤ簬璋风墿鍜屽叾浠栬胺鐗╃殑鍔犲伐锛屼互鐢熶骇鐒欑儰浜у搧銆侟/div>

銆€銆€缁忚繃璇勪及锛屼笓瀹跺皬缁勮涓猴紝涓嶈兘鎺掗櫎閫氳繃楗鎺ヨЕ寮曡捣杩囨晱鍙嶅簲鐨勯闄╋紝浣嗚繖绉嶆儏鍐靛彂鐢熺殑鍙兘鎬у緢浣庛€傛牴鎹墍鎻愪緵鐨勬暟鎹紝灏忕粍寰楀嚭缁撹锛岃椋熷搧閰跺湪棰勬湡鐨勪娇鐢ㄦ潯浠朵笅涓嶄細寮曡捣瀹夊叏闂銆傞儴鍒嗗師鏂囨姤閬撳涓嬶細

銆€銆€The food enzyme endo-1,4-β-xylanase (4-β-D-xylan xylanohydrolase; EC 3.2.1.8) is produced with the genetically modified Bacillus subtilis strain DP-Ezd119 by Genencor Internatio nal B.V. The production strain meets the requirements for the qualified presumption of safety (QPS) approach. The genetic modifications do not give rise to safety concerns. The food enzyme was co nsidered free from viable cells of the production organism and its DNA. The food enzyme is intended to be used in the processing of cereals and other grains for the production of baked products. Dietary exposure was estimated to be up to 0.085 mg total organic solids/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of co ncerns resulting from the food enzyme manufacturing process, toxicity tests were co nsidered unnecessary by the Panel. A search for the homology of the amino acid sequence of the endo-1,4-β-xylanase to known allergens was made, and no match was found. The Panel co nsidered that a risk of allergic reactions upon dietary exposure to the food enzyme cannot be excluded, but the likelihood is low. ba sed on the data provided, the Panel co ncluded that this food enzyme does not give rise to safety co ncerns under the intended co nditions of use.

銆€銆€ 鏈枃鐢遍鍝佷紮浼寸綉椋熷搧璧勮涓績缂栬緫锛屼緵缃戝弸鍙傝€冿紝鏈変换浣曠枒闂紝璇疯仈绯籲ews@www.sqrdapp.com銆侟/span>